MOVE Medacta Group SA

SWX · CH · Healthcare · Medical Devices · medacta.com

113.40CHF-0.18%Mkt Cap: 2.58B $P/E: 30.983d ago

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools f…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap2.58B USD

Enterprise Value2.91B USD

Revenue (TTM)807.87M USD

Gross Profit523.47M USD

Net Income (TTM)108.95M USD

Revenue/Share35.52 CHF

Last Price113.40 CHF

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees2.3K

CountryCH

SectorHealthcare

IndustryMedical Devices

ISINCH0468525222

Valuation

P/E (Trailing)30.98

P/E (Forward)21.17

PEG—

EV/EBITDA14.96

EV/Revenue3.60

P/S3.20

P/B4.95

EPS (TTM)3.67

EPS (Forward)5.37

52W Range

107.409% of range177.20

52W High177.20 CHF

52W Low107.40 CHF

Profitability

Gross Margin67.07%

Oper. Margin14.95%

EBITDA Margin24.09%

Profit Margin13.96%

ROE20.91%

ROA10.40%

Growth

Revenue Growth7.00%

Earnings Growth-30.20%

Cash Flow & Leverage

Operating CF174.22M USD

CapEx (TTM)163.32M USD

FCF Margin-7.13%

FCF Yield-2.23%

Net Debt324.81M USD

Net Debt/EBITDA1.67

Balance Sheet

Debt/Equity0.57

Current Ratio2.10

Quick Ratio0.74

Book Value/Sh22.93 CHF

Cash/Share1.80 CHF

Dividends

Fwd Div Rate1.10 CHF

Trail. Div Rate1.18 CHF

Div. Yield0.96%

5Y Avg Yield—

Payout Ratio30.76%

Ex-Div DateMay 7, 2026

Pay DateMay 13, 2025

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)160.74 CHF

Upside (mean)+41.7%

Target Range119.82 CHF – 190.56 CHF

119.82+41.7% to mean190.56

# Analysts6

Ownership

Shares Out.19.95M

Float6.03M

Insiders69.66%

Institutions11.88%

Technical

SMA 50124.69 (-9.1%)

SMA 200143.25 (-20.8%)

Beta0.97

S&P 52W Chg13.94%

Avg Vol (30d)34.36K

Avg Vol (10d)41.08K

Technical Indicators

RSI (14)38.1

MACD-3.0483

MACD Signal-3.7668

MACD Hist.+0.7185

BB Upper122.50 CHF

BB Middle114.51 CHF

BB Lower106.52 CHF

BB Width13.96%

ATR (14)3.324 CHF

Vol Ratio (20d)0.57x